Almirall SA | 12.54 / +0.24% |
Date/Time | 04/15 / 12:05 |
Chg. / Chg.(%) | 0.03 / +0.24% |
Bid | 12.52 / 426 |
Ask | 12.54 / 172 |
Open | 12.51 |
Previous Close | 12.51 |
High | 12.62 |
Low | 12.47 |
Volume [EUR] | 65,635.81 |
Volume [Units] | 9,156 |
Price fixings | 61 |
ISIN | ES0157097017 |
Security | ALM/E |
Exchange | Cboe Europe DXE |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Madrid | 12.5400 | ![]() |
79,807 |
Cboe Europe .. | 12.54 | ![]() |
9,156 |
Turquoise | 12.56 | ![]() |
3,669 |
Frankfurt | 12.4700 | ![]() |
0 |
Berlin | 12.470 | ![]() |
0 |
Lang & Schwa.. | 12.480 | ![]() |
|
Stuttgart | 12.330 | ![]() |
|
London Inter.. | 12.44 | 10,807 | |
TradeGate | 12.41 | 640 | |
Cboe Europe .. | 12.61 | 1,369 | |
Cboe Europe .. | 12.64 | 790 | |
Nasdaq Other.. | 15.0000 | 1,000 |
News
- Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/01/2021 / 22:01 - GlobeNewswire - Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
03/24/2021 / 12:00 - GlobeNewswire - Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
03/01/2021 / 22:01 - GlobeNewswire - Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
03/01/2021 / 13:05 - GlobeNewswire - Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
02/24/2021 / 22:01 - GlobeNewswire